Moynihan BGA. The ritual of a surgical operation. Br J Surg.1920;8:27-35.827
1920
[CrossRef]
Page CP, Bohnen JM, Fletcher JR, McManus AT, Solomkin JS, Wittmann DH. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg.1993;128:79-88.12879
1993
[PubMed]
Bratzler DW, Houck PM; Surgical Infection Prevention Guidelines Writers Workgroup; American Academy of Orthopaedic Surgeons; American Association of Critical Care Nurses; American Association of Nurse Anesthetists; American College of Surgeons; American College of Osteopathic Surgeons; American Geriatrics Society; American Society of Anesthesiologists; American Society of Colon and Rectal Surgeons; American Society of Health-System Pharmacists; American Society of PeriAnesthesia Nurses; Ascension Health; Association of periOperative Registered Nurses; Association for Professionals in Infection Control and Epidemiology; Infectious Diseases Society of America; Medical Letter; Premier; Society for Healthcare Epidemiology of America; Society of Thoracic Surgeons; Surgical Infection Society; Surgical Infection Prevention Guideline Writers Work Group. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis.2004;38:1706-15.381706
2004
[CrossRef]
Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis.2001;7:178-82.7178
2001
[CrossRef]
Mahomed NN, Barrett JA, Katz JN, Phillips CB, Losina E, Lew RA, Guadagnoli E, Harris WH, Poss R, Baron JA. Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. J Bone Joint Surg Am.2003;85:27-32.8527
2003
Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br.2005;87:844-50.87844
2005
[CrossRef]
Mahomed NN, Barrett J, Katz JN, Baron JA, Wright J, Losina E. Epidemiology of total knee replacement in the United States Medicare population. J Bone Joint Surg Am.2005;87:1222-8.871222
2005
[CrossRef]
Wilson MG, Kelley K, Thornhill TS. Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am.1990;72:878-83.72878
1990
Windsor RE, Bono JV. Infected total knee replacements. J Am Acad Orthop Surg.1994;2:44-53.244
1994
Tachdjian MO, Compere EL. Postoperative wound infections in orthopedic surgery; evaluation of prophylactic antibiotics. J Int Coll Surg.1957;28:797-805.28797
1957
Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery.1961;50:161-8.50161
1961
Fogelberg EV, Zitzmann EK, Stinchfield FE. Prophylactic penicillin in orthopaedic surgery. J Bone Joint Surg Am.1970;52:95-8.5295
1970
Charnley J. Postoperative infection after total hip replacement with special reference to air contamination in the operating room. Clin Orthop Relat Res.1972;87:167-87.87167
1972
[CrossRef]
Lidwell OM, Lowbury EJ, Whyte W, Blowers R, Stanley SJ, Lowe D. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. Br Med J (Clin Res Ed).1982;285:10-4.28510
1982
[CrossRef]
Ayers DC, Dennis DA, Johanson NA, Pellegrini VD Jr. Common complications of total knee arthroplasty. J Bone Joint Surg Am.1997;79:278-311.79278
1997
Rao N, Cannella B, Crossett LS, Yates AJ Jr, McGough R 3rd. A preoperative decolonization protocol for Staphylococcus aureus prevents orthopaedic infections. Clin Orthop Relat Res.2008;466:1343-8.4661343
2008
[CrossRef]
Fulkerson E, Valle CJ, Wise B, Walsh M, Preston C, Di Cesare PE. Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg Am.2006;88:1231-7.881231
2006
[CrossRef]
Fitzgerald RH, Jr. Infected total hip arthroplasty: diagnosis and treatment. J Am Acad Orthop Surg.1995;3:249-62.3249
1995
Costerton JW. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res.2005;437:7-11.4377
2005
Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science.1999;284:1318-22.2841318
1999
[CrossRef]
Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother.2001;45:999-1007.45999
2001
[CrossRef]
Hare R, Thomas CG. The transmission of Staphylococcus aureus. Br Med J.1956;2:840-4.2840
1956
[CrossRef]
Ritter MA. Operating room environment. Clin Orthop Relat Res.1999;369:103-9.369103
1999
[CrossRef]
Passaro DJ, Waring L, Armstrong R, Bolding F, Bouvier B, Rosenberg J, Reingold AW, McQuitty M, Philpott SM, Jarvis WR, Werner SB, Tompkins LS, Vugia DJ. Postoperative Serratia marcescens wound infections traced to an out-of-hospital source. J Infect Dis.1997;175:992-5.175992
1997
[CrossRef]
Veber B, Gachot B, Bedos JP, Wolff M. Severe sepsis after intravenous injection of contaminated propofol. Anesthesiology.1994;80:712-3.80712
1994
[CrossRef]
Mandell GL, Bennet JE, Dolin R, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed, vol 2. New York: Elsevier/Churchill Livingstone; 2005.
2005
Forse RA, Karam B, MacLean LD, Christou NV. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery.1989;106:750-7.106750
1989
ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. American Society of Health-System Pharmacists. Am J Health Syst Pharm.1999;56:1839-88.561839
1999
Neu HC. Cephalosporin antibiotics as applied in surgery of bones and joints. Clin Orthop Relat Res.1984;190:50-64.19050
1984
Oishi CS, Carrion WV, Hoaglund FT. Use of parenteral prophylactic antibiotics in clean orthopaedic surgery. A review of the literature. Clin Orthop Relat Res.1993;296:249-55.296249
1993
Schurman DJ, Hirshman HP, Kajiyama G, Moser K, Burton DS. Cefazolin concentrations in bone and synovial fluid. J Bone Joint Surg Am.1978;60:359-62.60359
1978
Darley ES, MacGowan AP. Antibiotic treatment of gram-positive bone and joint infections. J Antimicrob Chemother.2004;53:928-35.53928
2004
[CrossRef]
Fletcher N, Sofianos D, Berkes MB, Obremskey WT. Prevention of perioperative infection. J Bone Joint Surg Am.2007;89:1605-18.891605
2007
[CrossRef]
Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med.1992;326:281-6.326281
1992
[CrossRef]
Bannister GC, Auchincloss JM, Johnson DP, Newman JH. The timing of tourniquet application in relation to prophylactic antibiotic administration. J Bone Joint Surg Br.1988;70:322-4.70322
1988
Turano A. New clinical data on the prophylaxis of infections in abdominal, gynecologic, and urologic surgery. Multicenter Study Group. Am J Surg.1992;164(4A Suppl):16S-20S.16416S
1992
[CrossRef]
Niederhauser U, Vogt M, Vogt P, Genoni M, Kunzli A, Turina MI. Cardiac surgery in a high-risk group of patients: is prolonged postoperative antibiotic prophylaxis effective? J Thorac Cardiovasc Surg.1997;114:162-8.114162
1997
[CrossRef]
Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation.2000;101:2916-21.1012916
2000
Wymenga AB, Hekster YA, Theeuwes A, Muytjens HL, van Horn JR, Slooff TJ. Antibiotic use after cefuroxime prophylaxis in hip and knee joint replacement. Clin Pharmacol Ther.1991;50:215-20.50215
1991
[CrossRef]
Kriaras I, Michalopoulos A, Turina M, Geroulanos S. Evolution of antimicrobial prophylaxis in cardiovascular surgery. Eur J Cardiothorac Surg.2000;18:440-6.18440
2000
[CrossRef]
Williams DN, Gustilo RB. The use of preventive antibiotics in orthopaedic surgery. Clin Orthop Relat Res.1984;190:83-8.19083
1984
Heydemann JS, Nelson CL. Short-term preventive antibiotics. Clin Orthop Relat Res.1986;205:184-7.205184
1986
Mauerhan DR, Nelson CL, Smith DL, Fitzgerald RH Jr, Slama TG, Petty RW, Jones RE, Evans RP. Prophylaxis against infection in total joint arthroplasty. One day of cefuroxime compared with three days of cefazolin. J Bone Joint Surg Am.1994;76:39-45.7639
1994
Hota B, Ellenbogen C, Hayden MK, Aroutcheva A, Rice TW, Weinstein RA. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission? Arch Intern Med.2007;167:1026-33. Erratum in: Arch Intern Med. 2007;167:1455.1671026
2007
[CrossRef]
Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med.2005;352:1436-44.3521436
2005
[CrossRef]
Phillips JE, Crane TP, Noy M, Elliott TS, Grimer RJ. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br.2006;88:943-8.88943
2006
[CrossRef]
American Academy of Orthopaedic Surgeons. The use of prophylactic antibiotics in orthopaedic medicine and the emergence of vancomycin-resistant bacteria. 1998. Revised 2002. . Accessed 2008 Apr 15.
1998
http://www.aaos.org/about/papers/advistmt/1016.asp
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol.1999;20:250-80.20250
1999
[CrossRef]
Levine DP. Vancomycin: understanding its past and preserving its future. South Med J.2008;101:284-91.101284
2008
[CrossRef]
Graziani AL, Lawson LA, Gibson GA, Steinberg MA, MacGregor RR. Vancomycin concentrations in infected and noninfected human bone. Antimicrob Agents Chemother.1988;32:1320-2.321320
1988
Eshkenazi AU, Garti A, Tamir L, Hendel D. Serum and synovial vancomycin concentrations following prophylactic administration in knee arthroplasty. Am J Knee Surg.2001;14:221-3.14221
2001
Sivagnanam S, Deleu D. Red man syndrome. Crit Care.2003;7:119-20.7119
2003
[CrossRef]
Sanford JP, Gilbert, DN, Moellering, RC Jr, Sande MA, editors. The Sanford guide to antimicrobial therapy. 30th ed. Antimicrobial therapy. Hyde Park, VT: Jeb C. Sanford; 2000. Table 9B: Summary of current antibiotic dosage and side-effects; p 64-6.
2000
McNamara DR, Steckelberg JM. Vancomycin. J Am Acad Orthop Surg.2005;13:89-92.1389
2005
Finkelstein R, Rabino G, Mashiah T, Bar-El Y, Adler Z, Kertzman V, Cohen O, Milo S. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg.2002;123:326-32.123326
2002
[CrossRef]
Ritter MA, Barzilauskas CD, Faris PM, Keating EM. Vancomycin prophylaxis and elective total joint arthroplasty. Orthopedics.1989;12:1333-6.121333
1989
Savarese A, Nanni ML, Pasquali C, Egidio AC. Vancomycin prophylaxis in joint arthroplasty. Chir Organi Mov.1999;84:247-51.84247
1999
Centers for Disease Control and Prevention (CDC). Reduced susceptibility of Staphylococcus aureus to vancomycin—Japan, 1996. MMWR Morb Mortal Wkly Rep.1997;46:624-6.46624
1997
Centers for Disease Control and Prevention (CDC). Staphylococcus aureus resistant to vancomycin—United States, 2002. MMWR Morb Mortal Wkly Rep.2002;51:565-7.51565
2002
Eggimann P, Pittet D. Infection control in the ICU. Chest.2001;120:2059-93.1202059
2001
[CrossRef]
European Antimicrobial Resistance Surveillance System (EARSS). Annual report 2004. Bilthoven, The Netherlands: RIVM; 2005.
2005
Robicsek A, Beaumont JL, Paule SM, Hacek DM, Thomson RB Jr, Kaul KL, King P, Peterson LR. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med.2008;148:409-18.148409
2008
Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, Twombley J, French PP, Herwaldt LA; Mupirocin and the Risk of Staphylococcus Aureus Study Team. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med.2002;346:1871-7.3461871
2002
[CrossRef]
Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, Bogaers-Hofman D, de Baere GA, Stuurman A, van Belkum A, Kluytmans JA. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis.2002;35:353-8.35353
2002
[CrossRef]
Hacek DM, Robb WJ, Paule SM, Kudrna JC, Stamos VP, Peterson LR. Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res.2008;466:1349-55.4661349
2008
[CrossRef]
Buchholz HW, Elson RA, Engelbrecht E, Lodenkämper H, Rottger J, Siegel A. Management of deep infection of total hip replacement. J Bone Joint Surg Br.1981;63:342-53.63342
1981
Josefsson G, Lindberg L, Wiklander B. Systemic antibiotics and gentamicin-containing bone cement in the prophylaxis of postoperative infections in total hip arthroplasty. Clin Orthop Relat Res.1981;159:194-200.159194
1981
Josefsson G, Gudmundsson G, Kolmert L, Wijkström S. Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty. A five-year survey of 1688 hips. Clin Orthop Relat Res.1990;253:173-8.253173
1990
Jiranek WA, Hanssen AD, Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am.2006;88:2487-500.882487
2006
[CrossRef]